>

CAN FITE Stock Profile

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>CAN</div>
Analyze Filter   Check how we calculate scores
Equity ratings for CAN FITE BIOPHARMA are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 27, 2019 and ending today February 25, 2020. Click here to learn more.
CAN FITE BIOPHARMA cannot be verified against its exchange. It appears that CAN FITE is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

CAN FITE Profile

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel. CAN FITE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 7 people.. The public information regarding CAN FITE BIOPHARMA's current market price is not available at this time.
Legal NameCAN FITE BIOPHARMA
CEO, DirectorPnina FishmanView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
CAN FITE BIOPHARMA (CANF) is traded on Tel Aviv Stock Exchange in Israel and employs 7 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.42 B. CAN FITE BIOPHARMA operates under Healthcare sector and is part of Biotechnology industry. The entity has 0 outstanding shares. CAN-FITE BIOPHARMA has accumulated about 3.21 M in cash with (4.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Check CAN FITE Probability Of Bankruptcy

CAN FITE Stock Against Markets

CAN FITE BIOPHARMA cannot be verified against its exchange. It appears that CAN FITE is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

CAN FITE Corporate Executives

Check out Trending Equities. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Company logos by clearbit